BamSEC and AlphaSense Join Forces
Learn More

Pharmasset Inc

Formerly NASDAQ: VRUS
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-K 75 pages Collaboration Agreement
12/34/56
EX-10.1
from 8-K 6 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 10-Q 6 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 4 pages First Extension and Modification of Lease
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to License Agreement
12/34/56
EX-10.2
from 8-K 9 pages Form of Subscription Agreement
12/34/56
EX-10.1
from 8-K 38 pages 4,678,000 Shares Pharmasset, Inc. Common Stock (Par Value $0.001 Per Share) Placement Agency Agreement
12/34/56
EX-10.2
from 8-K 2 pages Secured Promissory Note
12/34/56
EX-10.25
from 10-K 5 pages License Agreement
12/34/56
EX-10.24
from 10-K 18 pages Manufacturing Services Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Form of Indemnity Agreement
12/34/56
EX-10.2
from 8-K 6 pages Form of Investor Purchase Agreement
12/34/56
EX-10.1
from 8-K 39 pages 1,450,000 Shares Pharmasset, Inc. Common Stock (Par Value $0.001 Per Share) Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 2 pages Secured Promissory Note
12/34/56
EX-10.1
from 8-K 3 pages Secured Promissory Note
12/34/56
EX-10.10
from S-1/A 81 pages License Agreement by and Between Pharmasset, Inc. and Rfs Pharma LLC Dated as of February 10, 2006
12/34/56
EX-10.5
from S-1/A 12 pages Non-Exclusive Sublicense Agreement Between Apath, L.L.C. and Pharmasset, Inc. for Hcv Replicon and Related Intellectual Property
12/34/56
EX-10.4
from S-1/A 48 pages April 24, 2003 Exclusive Patent and Know How License Agreement by and Between Pharmasset, Ltd (Licensor) and Primagen Holding B.V. (Licensee) Concerning Pharmasset’s Mitochondrial Toxicity Technology
12/34/56
EX-10.2
from S-1/A 302 pages License Agreement Between Bukwang Pharm. Co., Ltd. and Pharmasset, Inc
12/34/56
EX-10.1
from S-1/A 71 pages Collaboration Agreement
12/34/56